Skip to content

Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer

Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03568981
Enrollment
200
Registered
2018-06-26
Start date
2018-04-11
Completion date
2023-04-11
Last updated
2018-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This study aim to investigate the effect of 5-fraction stereotactic partial breast irradiation and whole breast irradiation on patient-reported outcomes, cosmetic outcome, and breast tissue fibrosis in early-stage breast cancer.

Interventions

After breast- conservating surgery, all patients are allowed to receive partial breast irradiation or whole breast irradiation after surgery according to the international guidelines and physician's discretion.

RADIATIONWhole breast irradiation

After breast- conservating surgery, all patients are allowed to receive partial breast irradiation or whole breast irradiation after surgery according to the international guidelines and physician's discretion.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pathologically confirmed invasive breast carcinoma or ductal carcinoma in situ (DCIS) * Women who underwent breast-conservating surgery and have a plan to undergoing partial or whole breast irradiation * Good performance status (ECOG 0-1)

Exclusion criteria

* Recurrent breast cancer * History of ipsilateral breast irradiation * Positive resection margin status after breast surgery

Design outcomes

Primary

MeasureTime frameDescription
Change of patient reported psychosocial functioning scoreBefore radiotherapy (allowed to 8 weeks before radiotherapy)Patient reported psychosocial functioning measured in 7 point Likert scale
Change of patient reported patient treatment satisfaction scoreBefore radiotherapy (allowed to 8 weeks before radiotherapy)Patient reported patient treatment satisfaction measured in 7 point Likert scale
Change of patient reported physical functioning scoreBefore radiotherapy (allowed to 8 weeks before radiotherapy)Patient reported physical functioning measured in 7 point Likert scale
Change of patient reported body image scoreBefore radiotherapy (allowed to 8 weeks before radiotherapy)Patient reported body image score measured in 7 point Likert scale
Change of breast cosmesis measures (excellent/good/poor)Before radiotherapy (allowed to 8 weeks before radiotherapybreast cosmesis result is measures by BCCT.core (Breast Cancer Conservative Treatment cosmetic results) software \- Investigators will whether there are any changes on patient-reported outcomes, cosmetic outcome, and breast tissue fibrosis after radiotherapy. Any differences of theses parameters according to the radiotherapy techniques (PBI vs. WBI) will be examed.
Change of breast-tissue fibrosis measures (gram)Before radiotherapy (allowed to 8 weeks before radiotherapybreast-tissue fibrosis is measured by tissue compliance meter device.

Secondary

MeasureTime frameDescription
Incidence of Radiotherapy-related complicationsBefore radiotherapy (allowed to 8 weeks before radiotherapy)Investigators will check whether there are any kinds of radiotherapy-related complications after PBI or WBI. Any differences of complications according to the radiotherapy techniques will be examed.

Countries

South Korea

Contacts

Primary ContactYong Bae Kim, MD, PhD
ybkim3@yuhs.ac82-2228-8095

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026